Integrating technology, innovation and policy: COVID-19 and HTA

Mukherjee, Kanchan

doi:10.1016/j.hlpt.2021.01.003

Cited by 24 publications

(19 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…With the coming of the pandemic in India, there has been a number of initiatives to encourage and fast tract startups innovating on affordable and effective solutions addressing the dimensions of care associated with COVID-19(Mukherjee, 2021). Policy response to the startup sector in India during COVID-19 is similar to the global response reported in…”

mentioning

confidence: 73%

Healthcare startups and ecosystems: Insights from an emerging market economy

Mukherjee

2021

Preprint

Self Cite

View full text Add to dashboard Cite

Highlights This study addresses an important research gap in entrepreneurship literature i.e. healthcare startups and policies. Provides insights into the healthcare startup landscape and startup ecosystem in an emerging market economy i.e. India. Creates a convergent stream framework (CSF) to help conceptualize gaps across startup lifecycle which has relevance for researchers, entrepreneurs and policy makers globally. Highlights the need for a universal coherent, responsive and inclusive ecosystem for converting a crisis into an opportunity for achieving sustainable development goals.

show abstract

mentioning

confidence: 73%

Healthcare startups and ecosystems: Insights from an emerging market economy

Mukherjee

2021

Preprint

Self Cite

View full text Add to dashboard Cite

show abstract

“…With a noticeable rise of technologies being developed to address the COVID-19 situation, the role of HTA in addressing medical, ethical, economic, and social implications of a policy decision becomes even more important, however, while the use of HTA to inform policy decisions is well established in the high- income and upper-middle-income countries, its use and application in HSs has been limited in LMICs. 2 HTA has been increasingly considered to support health policy decisions in the MENA region. 25 …”

Section: Discussionmentioning

confidence: 99%

“…1 Integrating HTA within a country’s health innovation system would help in the smooth convergence of technology, innovation and policy for addressing systemic gaps. 2 HTA is immensely increasing not only in developed countries but also in developing countries. It reduces resource waste, inefficiencies, and inappropriate investments in Health Systems (HSs).…”

Section: Introductionmentioning

confidence: 99%

“… 10 And recently, the first HTA on a COVID-19 innovative health technology (from India) shows the value of HTA in providing evidence on efficiency, equity and quality of SARS-CoV-2 testing policy. 2 Implementing HTA is particularly important to improve health surveillance, HS management, health education, and clinical decision-making, and to support behavioral changes related to public-health priorities and long-term diseases management.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Health Technology Assessment in High, Middle, and Low-income Countries: New Systematic and Interdisciplinary Approach For Sound Informed-policy Making: Research Protocole

AlKhaldi

Basuoni

Matos

et al. 2021

RMHP

View full text Add to dashboard Cite

Technological innovation has a significant role in improving health systems (HSs) and achieving universal health coverage (UHC). The World Health Organization (WHO) has declared resolutions on Health Technology Assessment (HTA) and other global organizations emphasized on HTA systems to achieve the Sustainable Development Goals (SDGs). HTA is a modern multidisciplinary decision-making framework linking knowledge and policymaking by assessing the medical, social, economic, organizational, and ethical effects, and/or impacts within health and social systems. The research significance lies in the growing need for HTA at these moments than ever as it is seen as an essential development approach to tackle the current global challenges and pandemics, particularly in developing countries. The research aims to comprehensively evaluate and understand HTA systems concerning the level of knowledge about HTA, current HTA structure, practices, application, capacity, gaps, and solutions. The project starts in January 2021 and ends in January 2022 and will be carried out in seven countries: Canada, Switzerland, Brazil, Lebanon, Jordan, Palestine, and Tanzania. A mixed-methods, quantitative and qualitative, along with a literature review will be applied. In each country, ten HTA-associated institutions will complete an adapted electronic survey, developed by the WHO, and ten key-informants selected purposively from the government, academia, NGOs, and private sectors to participate in ten individual in-depth interviews. One government representative from each country will participate in one expanded inter-country workshop. Excel, IBM Statistical Package for the Social Sciences (SPSS), and MAXQDA software programs will be used for data management and analysis. The research will form cutting-edge evidence not only for the seven countries, but also for the global, regional, and national endeavors with regards to opening a room for HTA best application and optimization. It will reveal lessons learned, determine gaps, and build a well-enabled and institutionalized HTA for better UHC, health systems, and multi-sectoral development.

show abstract

“…A quantitative value to the above implications emerge from the findings from the second national serosurvey from India, which finds 26-32 infections for every reported case, increasing spread of the virus to rural areas and only 3% of seropositive individuals reporting symptoms, highlighting the limitations of symptom-directed testing. 9 During the last six months there have been many innovative developments in testing technology including newer better quality rapid antigen tests and the FELUDA diagnostic test which has shown to be cost effective for the health systems 10 and approved for use by India's medical device approval authority. However, while private hospitals have started procuring the FELUDA testing kits, it is not available in public hospitals.…”

Section: Discussionmentioning

confidence: 99%

COVID-19 situation in India: Artifact or Fact?

Mukherjee

2021

Preprint

Self Cite

View full text Add to dashboard Cite

One year after the SARS-CoV-2 virus was first reported, India holds the dubious distinction of having the second highest number of SARS-CoV-2 cases in the world. Accurate and reliable testing holds the key for effective surveillance and management of this pandemic. In this context, this study analyses the course of the pandemic in India tracing back to the beginning of the national lockdown and the subsequent eleven months. It uses the variables of testing speed and incremental change in cases over time to draw insights into the current situation. The incremental analysis findings are triangulated with the published findings of the second national household serosurveillance from India and the Health Technology Assessment (HTA) of the FELUDA diagnostic test; to understand the nuances with the current data and testing technology for drawing inferences. The study finds that even with the availability of better local testing technology and evidence, the testing policy has failed to incorporate them, resulting in inaccurate, unreliable data and spread of infection. The findings reveal the gap between science and policy in India which has implications for both policy makers and researchers. Unless this gap is bridged urgently, the Indian situation may easily become one of global sore points in the fight against this pandemic. Study implications For policy makers: Need to revise the existing SARS-CoV-2 testing policy in India based on evidence on cost effectiveness of new diagnostic technology and findings from the national serosurvey studies. For researchers: The starting point of any modeling or prediction studies of this pandemic in India will need to take into consideration the extent of undetected cases estimated to be 26-32 infections for every positive case reported.

show abstract

Integrating technology, innovation and policy: COVID-19 and HTA

Cited by 24 publications

References 10 publications

Healthcare startups and ecosystems: Insights from an emerging market economy

Healthcare startups and ecosystems: Insights from an emerging market economy

Health Technology Assessment in High, Middle, and Low-income Countries: New Systematic and Interdisciplinary Approach For Sound Informed-policy Making: Research Protocole

COVID-19 situation in India: Artifact or Fact?

Contact Info

Product

Resources

About